Photo For Article 1 (quality) 1540x800(1)
Photo For Article 1 (quality) 1540x800(1)
Photo For Article 1 (quality) 1540x800(1)
Photo For Article 1 (quality) 1540x800(1)
Photo For Article 1 (quality) 1540x800(1)

Why should CDMOs adhere to the new CDER's Rating System?

Sept. 26, 2023
Dive into excellence: Discover how FDA's QMM program & CDER's rating system empower CDMOs to ensure top-quality pharmaceuticals, prevent shortages & build reliability. Uncover benefits, challenges and actionable steps in our white paper.

Ensuring the safety and efficacy of pharmaceutical products is paramount in the health care industry. In this white paper, we delve into the FDA’s Quality Management Maturity Program’s benefits, the rating system's evaluation criteria, advantages for CDMOs, challenges they may encounter, and actionable steps to overcome these hurdles and achieve excellence in their quality management systems.

This content is sponsored by: